tiprankstipranks
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
Want to see HK:1276 full AI Analyst Report?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Financial Statements

9 Followers

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Financial Overview

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's market cap is currently HK$327.48B. The company's EPS TTM is HK$1.32; its P/E ratio is 36.57; and it has a dividend yield of 0.51%. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is HK$0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Mar 22
Income Statement
Total RevenueHK$ 35.19BHK$ 29.77BHK$ 25.26BHK$ 24.23BHK$ 31.02B
Gross ProfitHK$ 30.33BHK$ 25.68BHK$ 21.36BHK$ 20.26BHK$ 26.20B
Operating IncomeHK$ 10.00BHK$ 7.97BHK$ 5.43BHK$ 4.68BHK$ 4.54B
EBITDAHK$ 10.64BHK$ 8.46BHK$ 5.95BHK$ 5.19BHK$ 5.19B
Net IncomeHK$ 8.58BHK$ 6.74BHK$ 4.76BHK$ 4.45BHK$ 5.46B
Balance Sheet
Cash & Short-Term InvestmentsHK$ 45.69BHK$ 26.69BHK$ 22.95BHK$ 20.06BHK$ 22.90B
Total AssetsHK$ 77.73BHK$ 53.33BHK$ 48.21BHK$ 47.57BHK$ 48.03B
Total DebtHK$ 48.18MHK$ 73.44MHK$ 692.54MHK$ 1.91BHK$ 1.36B
Net DebtHK$ -45.51BHK$ -26.33BHK$ -22.15BHK$ -15.06BHK$ -15.31B
Total LiabilitiesHK$ 8.98BHK$ 4.30BHK$ 2.99BHK$ 4.31BHK$ 4.38B
Stockholders' EquityHK$ 68.17BHK$ 48.42BHK$ 44.55BHK$ 42.47BHK$ 42.82B
Cash Flow
Free Cash FlowHK$ 9.20BHK$ 5.80BHK$ 6.82BHK$ -827.89MHK$ 3.39B
Operating Cash FlowHK$ 12.50BHK$ 7.90BHK$ 8.46BHK$ 1.44BHK$ 5.40B
Investing Cash FlowHK$ -3.05BHK$ -2.03BHK$ 1.35BHK$ 444.51MHK$ -559.25M
Financing Cash FlowHK$ 8.66BHK$ -1.65BHK$ -3.48BHK$ -363.05MHK$ -1.62B
Currency in HKD

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Earnings and Revenue History

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Debt to Assets

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Cash Flow

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Forecast EPS vs Actual EPS